• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

Your favorite articles from Drug Delivery Business News in 2021

December 29, 2021 By Sean Whooley

Drug Delivery Business News

From continuous glucose monitors to insulin pens, plus needle-free injection devices and inhalers — here are the most popular articles on Drug Delivery Business News from 2021:   Links to your favorite articles: Dexcom CEO Kevin Sayer says G7 will be ‘wonderful’ Eli Lilly partners with four companies on insulin pen tech Scancell picks PharmaJet’s needle-free […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Pain Management, Pharmaceuticals, Respiratory Tagged With: Dexcom, Eli Lilly, Eli Lilly & Co., Garmin, Pear Therapeutics, PharmaJet, Scancell, Teva Pharmaceuticals

Novo Nordisk completes acquisition of Dicerna Pharmaceuticals

December 28, 2021 By Sean Whooley

Novo Nordisk Dicerna Pharmaceuticals

Novo Nordisk (NYSE:NVO) announced today that its acquisition of Dicerna Pharmaceuticals (NSDQ:DRNA) has been completed. Completion of the acquisition, initially announced on Nov. 18, 2021, follows the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) in connected on with Novo Nordisk’s cash tender offer for Dicerna at 11:59 p.m. […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Dicerna Pharmaceuticals, Novo Nordisk

FDA approves injectable atopic dermatitis treatment from LEO Pharma

December 28, 2021 By Sean Whooley

Leo Pharma

LEO Pharma announced today that it received FDA approval for its Adbry injection treatment for moderate-to-severe atopic dermatitis. Ballerup, Denmark-based LEO Pharma designed its Adbry injection for treating atopic dermatitis in adults aged 18 years or older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. According […]

Filed Under: Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals Tagged With: FDA, Leo Pharma

Waiting period for Novo Nordisk’s proposed acquisition of Dicerna expires

December 27, 2021 By Sean Whooley

Novo Nordisk Dicerna Pharmaceuticals

Dicerna Pharmaceuticals (NSDQ:DRNA) announced that a waiting period for a proposed acquisition by Novo Nordisk (NYSE:NVO) has expired. The announcement, made on Dec. 25, confirmed that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) in connected on with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m. ET on […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat Tagged With: Dicerna Pharmaceuticals, Novo Nordisk

Zacks says Medtronic will gain from expanded CMS coverage for CGMs

December 23, 2021 By Sean Whooley

Medtronic logo updated

Zacks Equity Research today reported that Medtronic (NYSE:MDT) stands to gain from yesterday’s CMS coverage expansion for diabetes technology. CMS’s expanded coverage, confirmed by Medtronic yesterday, covers all types of CGMs (continuous glucose monitors), including adjunctive and non-adjunctive CGMs. The coverage includes CGMs that integrate with Medtronic insulin pumps. Zacks said the new rule will likely […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Patient Monitoring, Wall Street Beat Tagged With: Medtronic

CMS expands Medicare coverage to CGMs that integrate with Medtronic insulin pumps

December 22, 2021 By Sean Whooley

Medtronic World Diabetes Day

Medtronic (NYSE:MDT) announced today that the U.S. Centers for Medicare & Medicaid Services (CMS) will expand coverage for CGMs. CMS’ expanded coverage covers all types of CGMs (continuous glucose monitors), including adjunctive and non-adjunctive CGMs, and it notably covers CGMs that integrate with Medtronic insulin pumps. According to a news release, the proposed rule was […]

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring Tagged With: Centers for Medicare and Medicaid Services (CMS), Medtronic, Reimbursement

Government warns on cybersecurity issue with Fresenius Kabi’s Agilia Connect infusion system

December 21, 2021 By Sean Whooley

Fresenius Kabi logo updated

The U.S. Cyber Security & Infrastructure Security Agency today issued a medical advisory for the Fresenius Kabi Agilia Connect infusion system. Fresenius Kabi’s Agilia Connect infusion system has been deemed “exploitable remotely/low attack complexity” by the agency. Successful exploitation of vulnerabilities could allow an attacker to gain access to sensitive information, modify settings or parameters […]

Filed Under: Auto-injectors, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: freseniuskabi, infusion pump, infusion systems

Senseonics wins CE mark for remote glucose monitoring app for Android users

December 21, 2021 By Sean Whooley

Eversense CGM Senseonics

Senseonics (NYSE:SENS) announced today that its Eversense NOW remote monitoring app for Android received CE mark approval. Germantown, Maryland-based Senseonics already received such approval for the Eversense NOW iOS platform and can now offer it in Europe on the Android operating system. The company expects to make the Eversense NOW remote monitoring app for Android […]

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Regulatory/Compliance, Technology Tagged With: Senseonics

12 of medtech’s biggest personnel changes in 2021

December 17, 2021 By Sean Whooley

Medtech personnel changes

As medtech companies continued to drive innovation throughout the past 12 months, a number of high-level executives led the way. Some of those companies and those executives opted for major changes over the course of 2021, though, with some high-profile moves from medtech giant to medtech giant. Here are some of the biggest personnel moves […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Personnel Tagged With: abbott, BD, Dexcom, embecta, Medtronic, Personnel, Personnel Moves

Boyd acquires MBK Tape Solutions, expands expertise in wearables, transdermal patches

December 16, 2021 By Sean Whooley

Boyd

Boyd Corporation announced today that it acquired MBK Tape Solutions and its multi-layered adhesive products. MBK manufactures and develops complex multi-layered adhesive products that bond, mount, monitor and protect for stick-to-skin applications in the regulated medical industry. Pleasanton, California-based Boyd said in a news release that the acquisition strengthens its medical material science capability across […]

Filed Under: Business/Financial News, Drug-Device Combinations, Mergers & Acquisitions Tagged With: Boyd, MBK Tape Solutions

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 132
  • Page 133
  • Page 134
  • Page 135
  • Page 136
  • Interim pages omitted …
  • Page 188
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS